Bumper Offer - Urjas oil Just @ Rs. 1
Oliza Pet 5 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Schizophrenia. Oliza Pet 5 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Oliza Pet 5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Some other side effects of Oliza Pet 5 Tablet have been listed ahead. Usually, these side effects of Oliza Pet 5 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Oliza Pet 5 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Oliza Pet 5 Tablet related warnings talks about Oliza Pet 5 Tablet's effects on the liver, heart and kidney.
Oliza Pet 5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Oliza Pet 5 Tablet in conditions like Tardive Dyskinesia, Depression. Other conditions have been mentioned below in the Oliza Pet 5 Tablet contraindications section.
Additionally, Oliza Pet 5 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Oliza Pet 5 Tablet is not safe while driving, and is is not addictive in nature.
Oliza Pet 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Oliza Pet 5 Tablet safe for pregnant women?
Oliza can have harmful effects in pregnant women. If you experience any discomfort after using Oliza, then discontinue the use and take your doctor's advice.
Is the use of Oliza Pet 5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Oliza. So it is adviced to consult the doctor before using it.
What is the effect of Oliza Pet 5 Tablet on the Kidneys?
There are no side effects of Oliza on the kidneys.
What is the effect of Oliza Pet 5 Tablet on the Liver?
Side effects of Oliza rarely affect the liver.
What is the effect of Oliza Pet 5 Tablet on the Heart?
Side effects of Oliza rarely affect the heart.
Oliza Pet 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Oliza Pet 5 Tablet unless your doctor advises you to do so -
Is this Oliza Pet 5 Tablet habit forming or addictive?
No, there is no any evidence that Oliza Pet 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Oliza Pet 5 Tablet. So it is best to avoid driving.
Is it safe?
Oliza Pet 5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Oliza Pet 5 Tablet can help with mental disorders.
Interaction between Food and Oliza Pet 5 Tablet
Taking Oliza Pet 5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Oliza Pet 5 Tablet
Taking Oliza Pet 5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
